Grit Biotechnology Unveils Cutting-Edge Clinical Developments at 2025 ASCO Conference Grit Biotechnology showcases innovative TIL therapies at the 2025 ASCO Annual Meeting in Chicago, detailing advancements in cancer treatments.

Grit Biotechnology Unveils Cutting-Edge Clinical Developments at 2025 ASCO Conference #China #Shanghai #GRIT_Biotechnology #ASCO_2025 #TIL_therapies

Grit Biotechnology Showcases Cutting-Edge Advances at ASGCT 2025 Annual Meeting Grit Biotechnology highlights innovative research in immunotherapy at the ASGCT 2025 annual meeting, presenting updates on promising clinical programs.

Grit Biotechnology Showcases Cutting-Edge Advances at ASGCT 2025 Annual Meeting #China #Shanghai #GRIT_Biotechnology #ASGCT #Vitalgen_BioPharma

GRIT Bio Welcomes Jie Jia, Ph.D., as New Chief Operating Officer to Drive Global Mission Shenzhen GRIT Biotechnology Co., Ltd. appoints Jie Jia, Ph.D., an experienced leader in the biopharmaceutical field, as COO, enhancing its global impact in cell therapies.

GRIT Bio Welcomes Jie Jia, Ph.D., as New Chief Operating Officer to Drive Global Mission #China #Shenzhen #biopharmaceuticals #GRIT_Biotechnology #Jie_Jia